Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

VEGFR

VEGFR are receptors for vascular endothelial growth factor and belong to receptor tyrosine kinases.

Items 41-50 of 55

Page
per page
  1. Telatinib (BAY 57-9352)
    A8550 Telatinib (BAY 57-9352)
    Target: VEGFR|PDGFR|c-Kit
    Summary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor
      insoluble in H2O; insoluble in EtOH; ≥20.5 mg/mL
  2. Vandetanib (ZD6474)
    A8555 Vandetanib (ZD6474)
    Target: VEGFR|EGFR
    Summary: VEGFR2/EGFR antagonist
      insoluble in H2O; ≥11.88 mg/mL
  3. SKLB1002
    B1305 SKLB1002
    Summary: VEGFR2 inhibitor,potent and ATP-competitve
  4. CP-673451
    B2173 CP-673451
    Target: PDGFR
    Summary: PDGFRα/β inhibitor,potent and selective
  5. Apatinib
    B2303 Apatinib
     1 Citation
    Summary: VEGFR2 inhibitor, orally bioavailable, selective
      ≥49.4 mg/mL
  6. BFH772
    B6199 BFH772
    Summary: VEGFR2 inhibitor
      ≥53.4 mg/mL
  7. BAW2881 (NVP-BAW2881)
    B7800 BAW2881 (NVP-BAW2881)
    Summary: VEGFR inhibitor
      ≥42.4 mg/mL
  8. MAZ51
    C3342 MAZ51
    Target: VEGFR
    Summary: VEGFR3 antagonist
      insoluble in EtOH; insoluble in H2O; ≥31.4 mg/mL
  9. Tivozanib (hydrate)
    C3415 Tivozanib (hydrate)
    Summary: VEGFR inhibitor, orally available
      ≤25 mg/mL
  10. AAL-993
    C3730 AAL-993
    Summary: VEGF receptors inhibitor
      ≤1 mg/mL

Items 41-50 of 55

Page
per page